Child cancer patients at no greater risk of severe COVID-19 infection
Results from a study of children with cancer who tested positive for COVID-19 has found they were not at an increased risk of getting a severe coronavirus infection.
Science News
New treatment could spare early-stage rectal cancer patients life-altering side effects
A new less invasive treatment is safer than standard major surgery for early-stage rectal cancer, giving patients a better quality of life with fewer life-altering side effects, a pilot study shows.
Using targeted microbubbles to administer toxic cancer drugs
University of Leeds research has shown how microbubbles carrying powerful cancer drugs can be guided to the site of a tumour using antibodies.
COVID-19 advice may have reduced heart attack risks
A new study suggests that COVID-19 guidance in Sweden may have reduced people’s risks of having a heart attack.
How a protein ‘hunkers down’ to conserve energy
A visualisation made from nearly 100,000 electron microscope images has revealed the ingenious way a protein involved in muscle activity shuts itself down to conserve energy.
Genetic study reveals pre-eclampsia risk factors
A large international study has revealed that the genetic risk of pre-eclampsia, a potentially dangerous condition in pregnancy, is related to blood pressure and body mass index (BMI).
The protein helping to explain foot-and-mouth's infectiousness
Scientists have conducted a ‘molecular dissection’ of a part of the virus that causes foot-and-mouth disease, to try and understand why the pathogen is so infectious.
Ministers asked to intervene over rail research institute
Rail industry and civic leaders are urging the Government to accelerate construction of an advanced rail Institute that would provide a “...game-changing opportunity for the UK”.
Using research power to tackle global issues
The University of Leeds has secured part of a new £147 million research initiative to work with developing nations on the world's biggest challenges.
Pre-surgery chemotherapy benefits to be explored
The benefits of giving chemotherapy before surgery to bowel cancer patients will be further explored in a new £3.4 million trial, one of three awarded regional funding.